The Anup Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:42 am

Competitors of The Anup Engineering Ltd

All Competitor Stocks of The Anup Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:30 am

Below is a detailed analysis of the quarterly data for The Anup Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 175.00 Cr.. The value appears to be declining and may need further review. It has decreased from 222.00 Cr. (Mar 2025) to 175.00 Cr., marking a decrease of 47.00 Cr..
• For Expenses, as of Jun 2025, the value is 135.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 172.00 Cr. (Mar 2025) to 135.00 Cr., marking a decrease of 37.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 10.00 Cr..
• For OPM %, as of Jun 2025, the value is 23.00%. The value appears strong and on an upward trend. It has increased from 22.00% (Mar 2025) to 23.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.11. The value appears to be declining and may need further review. It has decreased from 15.75 (Mar 2025) to 13.11, marking a decrease of 2.64.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:19 am

Growth

Last Updated: September 5, 2025, 1:41 pm

Balance Sheet

Last Updated: August 11, 2025, 2:56 pm

Below is a detailed analysis of the balance sheet data for The Anup Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2023) to 20.00 Cr., marking an increase of 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 428.00 Cr. (Mar 2023) to 592.00 Cr., marking an increase of 164.00 Cr..
• For Borrowings, as of Mar 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 34.00 Cr. (Mar 2023) to 32.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 282.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 171.00 Cr. (Mar 2023) to 282.00 Cr., marking an increase of 111.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 926.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 643.00 Cr. (Mar 2023) to 926.00 Cr., marking an increase of 283.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2023) to 363.00 Cr., marking an increase of 146.00 Cr..
• For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2023) to 10.00 Cr., marking a decrease of 77.00 Cr..
• For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2023) to 11.00 Cr., marking an increase of 11.00 Cr..
• For Other Assets, as of Mar 2025, the value is 543.00 Cr.. The value appears strong and on an upward trend. It has increased from 338.00 Cr. (Mar 2023) to 543.00 Cr., marking an increase of 205.00 Cr..
• For Total Assets, as of Mar 2025, the value is 926.00 Cr.. The value appears strong and on an upward trend. It has increased from 643.00 Cr. (Mar 2023) to 926.00 Cr., marking an increase of 283.00 Cr..

Notably, the Reserves (592.00 Cr.) exceed the Borrowings (32.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for The Anup Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 59.25. This value is within the healthy range. It has increased from 52.01 (Mar 23) to 59.25, marking an increase of 7.24.
• For Diluted EPS (Rs.), as of Mar 25, the value is 59.04. This value is within the healthy range. It has increased from 51.68 (Mar 23) to 59.04, marking an increase of 7.36.
• For Cash EPS (Rs.), as of Mar 25, the value is 70.97. This value is within the healthy range. It has increased from 64.64 (Mar 23) to 70.97, marking an increase of 6.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 305.57. It has decreased from 442.27 (Mar 23) to 305.57, marking a decrease of 136.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 305.57. It has decreased from 442.27 (Mar 23) to 305.57, marking a decrease of 136.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 365.91. It has decreased from 415.65 (Mar 23) to 365.91, marking a decrease of 49.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 85.07. This value is within the healthy range. It has increased from 84.83 (Mar 23) to 85.07, marking an increase of 0.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 73.17. This value is within the healthy range. It has increased from 72.16 (Mar 23) to 73.17, marking an increase of 1.01.
• For PBT / Share (Rs.), as of Mar 25, the value is 71.50. This value is within the healthy range. It has increased from 70.73 (Mar 23) to 71.50, marking an increase of 0.77.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 59.07. This value is within the healthy range. It has increased from 51.97 (Mar 23) to 59.07, marking an increase of 7.10.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 59.07. This value is within the healthy range. It has increased from 51.97 (Mar 23) to 59.07, marking an increase of 7.10.
• For PBDIT Margin (%), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 20.40 (Mar 23) to 23.24, marking an increase of 2.84.
• For PBIT Margin (%), as of Mar 25, the value is 19.99. This value is within the healthy range. It has increased from 17.35 (Mar 23) to 19.99, marking an increase of 2.64.
• For PBT Margin (%), as of Mar 25, the value is 19.54. This value is within the healthy range. It has increased from 17.01 (Mar 23) to 19.54, marking an increase of 2.53.
• For Net Profit Margin (%), as of Mar 25, the value is 16.14. This value exceeds the healthy maximum of 10. It has increased from 12.50 (Mar 23) to 16.14, marking an increase of 3.64.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has increased from 12.50 (Mar 23) to 16.14, marking an increase of 3.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.33. This value is within the healthy range. It has increased from 11.75 (Mar 23) to 19.33, marking an increase of 7.58.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 14.88 (Mar 23) to 22.91, marking an increase of 8.03.
• For Return On Assets (%), as of Mar 25, the value is 12.77. This value is within the healthy range. It has increased from 7.99 (Mar 23) to 12.77, marking an increase of 4.78.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 23) to 0.01, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.07 (Mar 23) to 0.04, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.70 (Mar 23) to 0.00, marking a decrease of 0.70.
• For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.05 (Mar 23) to 1.90, marking a decrease of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 1.39. This value is within the healthy range. It has increased from 1.27 (Mar 23) to 1.39, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 3.79 (Mar 23) to 0.00, marking a decrease of 3.79.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 33.66. This value is within the healthy range. It has increased from 15.37 (Mar 23) to 33.66, marking an increase of 18.29.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 28.02. This value is within the healthy range. It has increased from 12.35 (Mar 23) to 28.02, marking an increase of 15.67.
• For Earning Retention Ratio (%), as of Mar 25, the value is 66.34. This value is within the healthy range. It has decreased from 84.63 (Mar 23) to 66.34, marking a decrease of 18.29.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 71.98. This value exceeds the healthy maximum of 70. It has decreased from 87.65 (Mar 23) to 71.98, marking a decrease of 15.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 51.02. This value is within the healthy range. It has decreased from 59.61 (Mar 23) to 51.02, marking a decrease of 8.59.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.43. This value is within the healthy range. It has decreased from 37.52 (Mar 23) to 36.43, marking a decrease of 1.09.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,977.07. It has increased from 996.51 (Mar 23) to 6,977.07, marking an increase of 5,980.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.52. This value exceeds the healthy maximum of 3. It has increased from 2.42 (Mar 23) to 9.52, marking an increase of 7.10.
• For EV / EBITDA (X), as of Mar 25, the value is 40.96. This value exceeds the healthy maximum of 15. It has increased from 11.87 (Mar 23) to 40.96, marking an increase of 29.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.50. This value exceeds the healthy maximum of 3. It has increased from 2.42 (Mar 23) to 9.50, marking an increase of 7.08.
• For Retention Ratios (%), as of Mar 25, the value is 66.33. This value is within the healthy range. It has decreased from 84.62 (Mar 23) to 66.33, marking a decrease of 18.29.
• For Price / BV (X), as of Mar 25, the value is 11.38. This value exceeds the healthy maximum of 3. It has increased from 2.27 (Mar 23) to 11.38, marking an increase of 9.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.50. This value exceeds the healthy maximum of 3. It has increased from 2.42 (Mar 23) to 9.50, marking an increase of 7.08.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.01, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness